More FDA staff leave, following broad firings at drug agency
The FDA office that approves new drugs is seeing more staff leave in early retirements, following broad cuts this month that targeted almost 20% of workers at the agency. The departures, many of which include ...
The FDA office that approves new drugs is seeing more staff leave in early retirements, following broad cuts this month that targeted almost 20% of workers at the agency.
The departures, many of which include ...
